Recombinant Human CDK6/CCND3, His-tagged, Active
Cat.No. : | CDK6/CCND3-278H |
Product Overview : | Recombinant human full-length Recombinant full-length human CDK6 and CyclinD3 were co-expressed by baculovirus inSf9insect cells using an N-terminal His tag on both proteins. MW= 40kDa and CyclinD3 ~35kDa. |
- Specification
- Gene Information
- Related Products
Cat. No. : | CDK6/CCND3-278H |
Description : | CDK6 is a member of the cyclin-dependent family of protein kinases that are important regulators of cell cycle progression. CDK6 activity is regulated by the D-type cyclins and members of the INK4 family of CDK inhibitors. The CDK6 kinase activity is detected in mid-G1 phase of the cell cycle and is responsible for the phosphorylation and regulation of the activity of tumor suppressor protein Rb. Although CDK6 and CDK4 can both phosphorylate multiple residues in the Rb protein, they do so with different residue selectivity in vitro; CDK6 phosphorylates Thr821 while CDK4 phosphorylates Thr826 on Rb protein. |
Source : | Sf9 insect cells using baculovirus. |
Sequence : | Full-length. |
Applications : | Kinase Assay, Western Blot. |
Storage And Stability : | Store product at –70°C. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles. |
Gene Name : | CDK6 cyclin-dependent kinase 6 [ Homo sapiens ],CCND3 cyclin D3 [ Homo sapiens ] |
Synonyms : | CDK6; cyclin-dependent kinase 6; PLSTIRE; MGC59692;Cell division protein kinase 6;EC2.7.11.22; Serine/threonine-protein kinase; CCND3;cyclin D3; G1/S-specific cyclin-D3 |
Gene ID : | 1021,896 |
mRNA Refseq : | NM_001145306,NM_001136017 |
Protein Refseq : | NP_001138778,NP_001129489 |
UniProt ID : | Q00534, P30281 |
Chromosome Location : | 7q21-q22, 6p21 |
MIM : | 603368,123834 |
Pathway : | Cell cycle; Chronic myeloid leukemia; Glioma; Melanoma; Non-small cell lung cancer; Pancreatic cancer; Pathways in cancer; Small cell lung cancer; p53 signaling pathway; Cell Cycle, Mitotic;Jak-STAT signaling pathway; Wnt signaling pathway |
Function : | ATP binding; cyclin-dependent protein kinase activity; nucleotide binding; cyclin binding; transferase activity; protein kinase binding; protein binding |
Products Types
◆ Recombinant Protein | ||
CDK6-728H | Recombinant Human CDK6 Protein, His-tagged | +Inquiry |
CDK6-1032H | Active Recombinant Human CDK6 Protein, GST-Tagged | +Inquiry |
CDK6-27H | Recombinant Human CDK6/CCND2 Protein (Full length), N-GST-tagged | +Inquiry |
CDK6/CCND1-277H | Recombinant Human CDK6/CCND1, His-tagged, GST-tagged, Active | +Inquiry |
CDK6-565H | Recombinant Human CDK6 Protein, His (Fc)-Avi-tagged | +Inquiry |
◆ Lysates | ||
CDK6-7622HCL | Recombinant Human CDK6 293 Cell Lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionThe expression level of CDK6 is regulated by a variety of factors, including transcription factors, epigenetic modifications, and signal transduction pathways. These factors can affect the transcription and translation processes of the CDK6 gene, thereby regulating its expression level in cells.
There are several challenges in the development of CDK6 inhibitors, including issues such as inhibitor selectivity, drug resistance, and drug delivery. In addition, since CDK6 also has a certain function in normal cells, the side effects of inhibitors are also a factor to consider.
It plays an important role in stem cell biology. It is involved in the process of self-renewal and differentiation of stem cells, as well as in determining the fate of stem cells. By regulating the activity of CDK6, it is possible to influence the proliferation and fate selection of stem cells.
CDK6 inhibitors have been developed as potential anti-cancer drugs and have shown some efficacy in clinical trials. They block the progression of the cell cycle by inhibiting the activity of CDK6, thereby inhibiting the proliferation of cancer cells.
The activity of CDK6 is regulated at multiple levels, including binding to other cyclins and inhibitors, phosphorylation and dephosphorylation events, and transcriptional and post-translational modifications.
The role of CDK6 in different types of cancer may vary. It may act as a promoter in some cancers and as a suppressant in others. This difference can be related to factors such as the type, stage, and genetic background of the cancer.
Customer Reviews (3)
Write a reviewThe results obtained after analysis by SDS-PAGE or Western blot were good.
It has a wide range of applications and can be used in various biological experiments.
The purity of CDK6 is good, and the experimental results obtained are very accurate.
Ask a Question for All CDK6 Products
Required fields are marked with *
My Review for All CDK6 Products
Required fields are marked with *
Inquiry Basket